Tower Research Capital LLC (TRC)
Position in ELDN — Eledon Pharmaceuticals, Inc.
CIK 1533421
NEW YORK, NY
Position in ELDN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$51,038
+$37,952 QoQ
Shares Held
12,954
+204.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 159 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. ELDN ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in ELDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,038 | 12,954 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $13,086 | 4,249 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $41,300 | 27,351 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,632 | 10,669 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8 | 3 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $42,300 | 12,478 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $32,728 | 7,944 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,814 | 1,532 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $44,769 | 16,958 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,688 | 5,674 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,144 | 5,636 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,566 | 8,443 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,685 | 11,450 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,752 | 6,251 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,326 | 1,898 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $1,766 | 640 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $2,525 | 1,035 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,224 | 1,326 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,066 | 2,056 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $5,086 | 643 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 NVUS | — | 2,598 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||